Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey

Japanese Journal of Infectious Diseases

Volumn 58, Issue 5, 2005, Pages 309-312

  Elif Ozturk, C ^a   Sanic, Ahmet ^b   Kaya, Demet ^a   Ceyhan, Ismail ^c  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ARGININE; ASPARTIC ACID; BACTERIAL DNA; BACTERIAL PROTEIN; CYTOSINE; GUANINE; ISONIAZID; KATG PROTEIN; LEUCINE; LYSINE; PROLINE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; SERINE; STREPTOMYCIN; THREONINE; THYMINE; TUBERCULOSTATIC AGENT; VALINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HUMAN; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS; TURKEY (REPUBLIC);

AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POINT MUTATION; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, PULMONARY; TURKEY;

EID: 27744598657     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Soini, H. and Musser, J. M. (2001): Molecular diagnosis of mycobacteria. Clin. Chem., 47, 809-814.
2. Ramaswami, S. and Musser, J. M. (1998): Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis., 79, 3-29.
3. Slayden, R. A., Lee, R. E. and Barry, C. E., III (2000): Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol. Microbiol., 38, 514-525.
4. Slayden, R. A. and Barry, C. E., III (2000): The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect., 2, 659-669.
5. Riska, P. F., Jacobs, W. R., Jr. and Alland, D. (2000): Molecular determinants of drug resistance in tuberculosis. Int. J. Tuberc. Lung Dis., 4, 4-10.
6. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M. J., Matter, L., Schopfer, K. and Bodmer, T. (1993): Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
7. Kapur, V., Li, L. L., Iordanescu, S., Hamrick, M. R., Wanger, A., Kreiswirth, B. N. and Musser, J. M. (1994): Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol., 32, 1095-1098.
8. Springer, B., Kidan, Y. G., Prammananan, T., Ellrott, K., Böttger, E. C. and Sander, P. (2001): Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob. Agents Chemother., 45, 2877-2884.
9. Huang, H. N., Han, J. X., Wang, J. H., Song, C. Z., Liang, H. and Zhang, Z. L. (2003): rpsL gene analysis associated with streptomycin resistance in Mycobacterium tuberculosis. Yi Chuan Xue Bao, 30, 376-381 (text in Chinese).
10. Telenti, A. and Musser, J. M. (1997): Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother., 41, 1677-1681.
11. Kim, S. Y., Park, Y. J., Kim, W.-II., Lee, S. H., Chang, C. L., Kang, S. J. and Kang, C. S. (2003): Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn. Microbiol. Infect. Dis., 47, 497-502.
12. Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L. and Jacobs, W. R., Jr. (1994): Tuberculosis programme: framework for effective tuberculosis control. 35. World Health Organization. Publication no. WHO/TB/94.179. World Health Organization, Geneva, Switzerland.
13. Haas, W. H., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, P. B., Bretzel, G., Sticht-Groh, V. and Bremer, H. J. (1997): Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents Chemother., 41, 1601-1603.
14. Marttila, H. J., Soini, H., Huovinen, P. and Viljanen, M. K. (1996): katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob. Agents Chemother., 40, 2187-2189.
15. Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., Van Soolingen, D. and Van Embden, J. D. (1996): Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis., 173, 196-202.
16. Marttila, H. J., Soini, H., Eerola, E., Vyshnevskaya, E., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V. and Viljanen, M. K. (1998): A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother., 42, 2443-2445.
17. Rindi, L., Bianchi, L., Tortoli, E., Lari, N., Bonanni, D. and Garzelli, C. (2003): A real time PCR assay for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J. Microbiol. Methods, 55, 797-800.
18. Saint-Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M. and Cole, S. T. (1999): Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, katG, from Mycobacterium tuberculosis. Biochem. J., 338, 753-760.
19. Wengenack, N. L., Uhl, J. R., Stamand, A. L., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R. and Rusnak, F. (1997): Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J. Infect. Dis., 176, 722-727.
20. Mokrousov, I., Otten, T., Filipenko, M., Vyazovaya, A., Chrapov, E., Limeschenko, E., Steklova, L., Vyshnevskiy, B. and Narvskaya, O. (2002): Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol., 7, 2509-2512.
21. Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L. and York, D. F. (2000): Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung Dis., 80, 47-56.
22. Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Jr., Kramer, F. R. and Alland, D. (2000): Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother., 44, 103-110.
23. Ramaswamy, S. V., Dou, S. J., Rendon, A., Yang, Z., Cave, M. D. and Graviss, E. A. (2004): Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J. Med. Microbiol., 53, 107-113.
24. Mokrousov, I., Otten, T., Vyshnevskiy, B. and Narvskaya, O. (2003): Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob. Agents Chemother., 47, 2231-2235.
25. Cavusoglu, C., Hilmioglu, S., Guneri, S. and Bilgic, A. (2002): Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol., 40, 4435-4438.
26. Karahan, Z. C., Atalay, F., Uzun, M., Erturan, Z., Atasever, M. and Akar, N. (2004): Sequence analysis of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Turkey. Microb. Drug Resist., 10, 325-333.
27. Avkan Oguz, V., Eroglu, C., Guneri, S., Yapar, N., Oztop, A., Sanic, A. and Yuce, A.(2004): RpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey. J. Chemother., 16, 442-445.
28. Generozov, E. V., Akopian, T. A., Govorun, V. M., Chernousova, L. N., Larionova, E. E., Savinkova, S. N., Smirnova, T. G., Golyshevskaia, V. I. and Khomenko, A. G. (2000): Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia. Mol. Gen. Mikrobiol. Virusol., 1, 11-17 (in Russian).
29. Petrini, B. and Hoffner, S. (1999): Drug-resistant and multidrug-resistant tubercle bacilli. Int. J. Antimicrob. Agents, 13, 93-97.
30. Mokrousov, I., Otten, T., Vyazovaya, A., Limeschenko, E., Filipenko, M. L., Sola, C., Rastogi, N., Steklova, L., Vyshnevskiy, B. and Narvskaya, O. (2003): PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. Eur. J. Clin. Microbiol. Infect. Dis., 22, 342-348.
31. Katsukawa, C., Tamaru, A., Miyata, Y., Abe, C., Makino, M. and Suzuki, Y. (1997): Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. J. Appl. Microbiol., 83, 634-640.